Britain to provide anti-viral drug remdesivir to some COVID-19 patients
LONDON (Reuters) - Britain will provide the anti-viral drug remdesivir to certain COVID-19 patients that it is most likely to benefit as part of a collaboration with manufacturer Gilead Sciences, the health ministry said on Tuesday. The department of health said early data from clinical trials around the world showed that the drug could shorten the recovery time of COVID-19 patients by four days. 'This is probably the biggest step forward in the treatment of coronavirus since the crisis began,' health minister Matt Hancock told a government news conference.
LONDON (Reuters) - Britain will provide the anti-viral drug remdesivir to certain COVID-19 patients that it is most likely to benefit as part of a collaboration with manufacturer Gilead Sciences, the health ministry said on Tuesday.
The department of health said early data from clinical trials around the world showed that the drug could shorten the recovery time of COVID-19 patients by four days.
"This is probably the biggest step forward in the treatment of coronavirus since the crisis began," health minister Matt Hancock told a government news conference.
"These are very early steps, but we are determined to support the science and back the projects that show promise."
The government said the allocation of the drug would be determined by where it would have the greatest benefit, but did not say how many patients would be treated.
The U.S. National Institutes of Health (NIH) said last week that data from its trial of remdesivir showed that the drug offers the most benefit for COVID-19 patients who need extra oxygen but do not require mechanical ventilation.
The researchers also said that "given high mortality despite the use of remdesivir," it is likely that the drug would be more effective in combination with other treatments for COVID-19, the respiratory illness caused by the novel coronavirus.
Stephen Griffin, an associate professor at Leeds University, welcomed the move to use remdesivir, saying it would "likely mean that the most severe COVID-19 patients will receive it first". He said that while this approach was the most ethical, it also meant drug would not be a "magic bullet".
"We can instead hope for improved recovery rates and a reduction in patient mortality," Griffin said.
Gilead said it expects results from its own study of remdesivir in patients with moderate COVID-19 at the end of this month.
(Reporting by Alistair Smout, Kate Holton and Kate Kelland; editing by Guy Faulconbridge and Stephen Addison)
This story has not been edited by Firstpost staff and is generated by auto-feed.
By Robin Emmott and John Irish | BRUSSELS/PARIS BRUSSELS/PARIS France and Germany will agree to a U.S. plan for NATO to take a bigger role in the fight against Islamic militants at a meeting with President Donald Trump on Thursday, but insist the move is purely symbolic, four senior European diplomats said.The decision to allow the North Atlantic Treaty Organization to join the coalition against Islamic State in Syria and Iraq follows weeks of pressure on the two allies, who are wary of NATO confronting Russia in Syria and of alienating Arab countries who see NATO as pushing a pro-Western agenda."NATO as an institution will join the coalition," said one senior diplomat involved in the discussions. "The question is whether this just a symbolic gesture to the United States
BEIJING Chinese President Xi Jinping on Wednesday called for greater efforts to make the country's navy a world class one, strong in operations on, below and above the surface, as it steps up its ability to project power far from its shores.China's navy has taken an increasingly prominent role in recent months, with a rising star admiral taking command, its first aircraft carrier sailing around self-ruled Taiwan and a new aircraft carrier launched last month.With President Donald Trump promising a US shipbuilding spree and unnerving Beijing with his unpredictable approach on hot button issues including Taiwan and the South and East China Seas, China is pushing to narrow the gap with the U.S. Navy.Inspecting navy headquarters, Xi said the navy should "aim for the top ranks in the world", the Defence Ministry said in a statement about his visit."Building a strong and modern navy is an important mark of a top ranking global military," the ministry paraphrased Xi as saying.